Document And Entity Information
Document Information [Table]
Document Information [Line Items]
Document Type
Document Quarterly Report
Document Period End Date
Document Transition Report
Entity File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Shell Company
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Common Stock, Shares Outstanding
Entity Central Index Key
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Amendment Flag
Condensed Consolidated Balance Sheets
Statement [Table]
Class of Stock [Axis]
Class of Stock [Domain]
Series A Convertible Preferred Stock
Series A Convertible Preferred Stock
Series B Convertible Preferred Stock
Series B Convertible Preferred Stock
Statement [Line Items]
Company's equity incentive plans
Assets [Abstract]
ASSETS
Assets, Current [Abstract]
Current Assets
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Cash and cash equivalents
Accounts Receivable, after Allowance for Credit Loss, Current
Trade accounts receivable
Short-term investments
Short-term investments
Inventory, Net
Inventory
Prepaid Expense and Other Assets, Current
Prepaid expenses and other assets
Assets, Current
Total Current Assets
Property and equipment, net
Property, Plant and Equipment, Net
Property and equipment, net
Finite-Lived Intangible Assets, Net
Intangible assets, net
Intangible assets, net
Operating Lease, Right-of-Use Asset
Operating lease right-of-use assets
Restricted Cash, Noncurrent
Restricted cash
Other Assets, Noncurrent
Long-term assets
Assets
Total Assets
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities, Current [Abstract]
Current Liabilities
Accounts Payable, Current
Accounts payable
Accrued Liabilities and Other Liabilities
Accrued expenses and other liabilities
Notes Payable, Current
Note payable - current
Operating Lease, Liability, Current
Operating lease liabilities
Current portion included in current liabilities
Liabilities, Current
Total Current Liabilities
Liabilities, Noncurrent [Abstract]
Non-Current Liabilities
Operating Lease, Liability, Noncurrent
Operating lease liabilities - non-current
Long-term portion included in non-current liabilities
Deferred Income Tax Liabilities, Net
Deferred tax liabilities
Liabilities, Noncurrent
Total Non-Current Liabilities
Liabilities
Total Liabilities
Commitments and Contingencies
Commitments and contingencies
Condensed Consolidated Statements of Stockholders' Equity
Stockholders' Equity
Preferred Stock, Value, Issued
Preferred stock, Value
Common Stock, Value, Issued
Common stock, $0.000041666 par value; 650,000,000 shares authorized, 452,971,016 and 411,938,061 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Accumulated Other Comprehensive Income (Loss), Net of Tax
Accumulated other comprehensive income
Additional Paid in Capital
Additional paid-in capital
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Stockholders' Equity Attributable to Parent
Ending Balance
Beginning Balance
Total Stockholders' Equity
Liabilities and Equity
Total Liabilities and Stockholders' Equity
Preferred Stock, Par or Stated Value Per Share
Preferred stock, par or stated value per share
Preferred Stock, Shares Authorized
Preferred stock, shares authorized
Preferred Stock, Shares Issued
Preferred Stock, Shares Issued
Preferred Stock, Shares Outstanding
Preferred stock, shares outstanding
Common Stock, Par or Stated Value Per Share
Common stock, par or stated value per share
Common Stock, Shares Authorized
Common stock, shares authorized
Common Stock, Shares, Issued
Common Stock, Shares, Issued
Common stock, shares issued
Common Stock, Shares, Outstanding
Common Stock, Shares, Outstanding
Common stock, shares outstanding
Condensed Consolidated Statements of Operations
Revenue from Contract with Customer, Excluding Assessed Tax
Total revenue
Net revenue
Net sales
Revenue from Contract with Customer, Product and Service [Extensible Enumeration]
Operating Expenses [Abstract]
Expenses
Costs and expenses
Cost of Revenue
Cost of sales
Total cost of sales
Research and Development Expense
Research and development
Research and development
General and Administrative Expense
General and administrative
Selling, general, and administrative
Depreciation, Depletion and Amortization, Nonproduction
Depreciation and amortization
Costs and Expenses
Total costs and expenses
Operating Income (Loss)
Loss from operations
Nonoperating Income (Expense) [Abstract]
Other income
Investment Income, Interest
Interest and other income, net
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Net Loss before income taxes
Income Tax Expense (Benefit)
Income tax benefit (expense)
Income tax expense
Net Loss
Net Loss
Net Loss
Earnings Per Share, Basic
Net Loss Per Share of Common Stock, Basic (in dollars per share)
Earnings Per Share, Diluted
Net Loss Per Share of Common Stock, Diluted (in dollars per share)
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Shares of Common Stock Outstanding, Basic (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Shares of Common Stock Outstanding, Diluted (in shares)
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Non-cash stock-based compensation included in cost of sales and operating expenses
Amount of noncash expense for share-based payment arrangement included in cost of sales.
Non-cash Stock-Based Compensation Included in Cost of Sales
Non-cash stock-based compensation included in cost of sales
Amount of noncash expense for share-based payment arrangement included in Research and development.
Non-cash Stock-Based Compensation Included in Research and Development
Non-cash stock-based compensation included in research and development
Amount of noncash expense for share-based payment arrangement included in selling, general and administrative.
Non-cash Stock-Based Compensation Included in Selling, General and Administrative
Non-cash stock-based compensation included in selling, general and administrative
Share-based Compensation
Stock-based compensation expense
Share-based Compensation
Condensed Consolidated Statements of Comprehensive Loss
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract]
Other comprehensive loss:
Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax
Unrealized loss on investments
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax
Foreign currency translation adjustment
Foreign currency cumulative translation adjustment
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive Loss
Equity Components [Axis]
Equity Component [Domain]
Preferred Stock
Preferred Stock
Common Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Shares, Outstanding
Ending Balance (in Shares)
Beginning Balance (in Shares)
Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition
Stock-based compensation expense
Stock Issued During Period, Value, Employee Stock Purchase Plan
Common stock issued upon purchase of employee stock purchase plan
Stock Issued During Period, Shares, Employee Stock Purchase Plans
Common stock issued upon purchase of employee stock purchase plan (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures
Vesting of restricted shares issued for services (in shares)
Amount of increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).
Adjustment to Additional Paid in Capital, Income Tax Effect from Share-Based Compensations, Net
Tax payments related to shares retired for vested restricted stock units
Shares increase (decrease) in additional paid in capital (APIC) resulting from a tax benefit (deficiency) associated with an share-based compensation plan other than an employee stock ownership plan (ESOP).
Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net Shares
Tax payments related to shares retired for vested restricted stock units (in shares)
Stock Issued During Period, Value, Stock Options Exercised
Common stock issued upon exercise of stock options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Exercised
Common stock issued upon exercise of stock options (in shares)
Stock Issued During Period, Value, New Issues
Common stock sold in public and/or at the market offering, net of offering costs
Stock Issued During Period, Shares, New Issues
Common stock sold in public and/or at the market offering, net of offering costs (in shares)
Common stock sold in public offering
Amount of Common stock issued from preferred stock conversion.
Common Stock Issued From Preferred Stock Conversion
Common stock issued from preferred stock conversion
Number of Common stock issued from preferred stock conversion.
Common Stock Issued From Preferred Stock Conversion, Shares
Common stock issued from preferred stock conversion (in Shares)
Condensed Consolidated Statements of Cash Flows
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash Flows from Operating Activities
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Gain (Loss), Foreign Currency Transaction, before Tax
Unrealized foreign exchange loss (gain)
Amortization of Intangible Assets
Amortization of intangible assets
Operating Lease, Right-of-Use Asset, Amortization Expense
Amortization of right of use asset
Depreciation, Depletion and Amortization
Depreciation and amortization of property and equipment
Deferred Income Tax Expense (Benefit)
Deferred tax benefit
Inventory Write-down
Excess and obsolescence reserve
Accretion (Amortization) of Discounts and Premiums, Investments
Accretion of discounts and premiums on investments
Gain (Loss) on Disposition of Assets
Loss on asset disposals
Gain (Loss) on Extinguishment of Debt
Gain on loan forgiveness
Gain (Loss) on Termination of Lease
Gain on derecognition of lease assets and liabilities
Gain on termination of lease
Increase (Decrease) in Operating Capital [Abstract]
Changes in assets and liabilities:
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid expenses, other assets and long-term assets
Increase (Decrease) in Accounts Receivable
Trade accounts receivable
Increase (Decrease) in Inventories
Inventory
Increase (Decrease) in Operating Lease Liability
Operating lease liabilities
Increase (Decrease) in Accounts Payable
Accounts payable
Increase (Decrease) in Accrued Liabilities
Accrued expenses and other liabilities
Net Cash Provided by (Used in) Operating Activities
Net cash used in operating activities
Net cash used in operating activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash Flows from Investing Activities
Proceeds from Sale and Maturity of Debt Securities, Available-for-sale
Maturities of investments
Payments to Acquire Available-for-sale Securities
Purchase of investments
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Net Cash Provided by (Used in) Investing Activities
Net cash provided by (used in) investing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash Flows from Financing Activities
Payments Related to Tax Withholding for Share-based Compensation
Tax payments related to shares withheld for vested restricted stock units
The cash inflow from the additional capital contribution to the entity under Employee Stock Purchase Plan.
Proceeds from Issuance of Common Stock, Under Employee Stock Purchase Plan
Proceeds from the issuance of common stock under employee stock purchase plan
Proceeds from Stock Options Exercised
Proceeds from the issuance of common stock upon exercise of options
Proceeds from Issuance of Common Stock
Proceeds from the issuance of common stock, net
Net Cash Provided by (Used in) Financing Activities
Net cash provided by financing activities
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations
Effect of foreign exchange rate changes
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash, Cash Equivalents and Restricted Cash End of Period
Cash, Cash Equivalents and Restricted Cash Beginning of Period
Total cash, cash equivalents and restricted cash
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Supplemental disclosure of non-cash investing and financing activities:
Unrealized Gain (Loss) on Investments
Net unrealized loss on investments
The amount of acquisitions of property and equipment included in accounts payable and accrued expense.
Acquisitions Of Property And Equipment Included In Accounts Payable And Accrued Expense
Acquisition of property and equipment included in accounts payable and accrued expenses
Conversion of Stock, Amount Converted
Conversion of convertible preferred stock to common stock
Amount of increase in right-of-use asset obtained (Reduced) in exchange for operating lease liability from lease modifications.
Right of Use Asset Obtained (Reduced) In Exchange For Operating Lease Liability From Lease Modifications
Increase in lease liabilities due to obtaining right-of-use assets from lease modifications
GENERAL ORGANIZATION, BUSINESS AND LIQUIDITY
Business Description and Basis of Presentation [Text Block]
GENERAL ORGANIZATION, BUSINESS AND LIQUIDITY
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Significant Accounting Policies [Text Block]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
N/A.
CASH EQUIVALENTS AND INVESTMENTS
Cash, Cash Equivalents, and Short-term Investments [Text Block]
CASH EQUIVALENTS AND INVESTMENTS
INTANGIBLE ASSETS, NET
Intangible Assets Disclosure [Text Block]
INTANGIBLE ASSETS, NET
INVENTORY
Inventory Disclosure [Text Block]
INVENTORY
REVENUE
Revenue from Contract with Customer [Text Block]
REVENUE
PROPERTY AND EQUIPMENT, NET
Property, Plant and Equipment Disclosure [Text Block]
PROPERTY AND EQUIPMENT, NET
ACCRUED EXPENSES
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
ACCRUED EXPENSES
STOCKHOLDERS' EQUITY
Stockholders' Equity Note Disclosure [Text Block]
STOCKHOLDERS' EQUITY
SEGMENT INFORMATION
Segment Reporting Disclosure [Text Block]
SEGMENT INFORMATION
LICENSES AND AGREEMENTS
The entire disclosure for licenses and agreements.
Licenses And Agreements Disclosure [Text Block]
LICENSES AND AGREEMENTS
LEASES
Lessee, Operating Leases [Text Block]
LEASES
LEGAL PROCEEDINGS
Contingencies Disclosure [Text Block]
LEGAL PROCEEDINGS
INCOME TAXES
Income Tax Disclosure [Text Block]
INCOME TAXES
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash, Cash Equivalents, and Investments
Disclosure of accounting policy for restricted cash.
Restricted Cash [Policy Text Block]
Restricted Cash
Business Combinations Policy [Policy Text Block]
Asset Acquisitions
Disclosure of inventory and cost of sales accounting policy.
Inventories and Cost of Sales [Policy Text Block]
Inventory and Cost of Sales
Accounts Receivable [Policy Text Block]
Trade Accounts Receivable
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Intangible Assets
Lessee, Leases [Policy Text Block]
Leases
Revenue from Contract with Customer [Policy Text Block]
Revenue Recognition
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock-Based Compensation
Research and Development Expense, Policy [Policy Text Block]
Accrued Research and Development Costs
Selling, General and Administrative Expenses, Policy [Policy Text Block]
Selling, general, and administrative expense
Costs Associated with Exit or Disposal Activity or Restructuring [Policy Text Block]
Restructuring Charges
Earnings Per Share, Policy [Policy Text Block]
Net Loss per Share
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Consolidation, Policy [Policy Text Block]
Principles of Consolidation
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Foreign Currency Translation
Segment Reporting, Policy [Policy Text Block]
Segment Reporting
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued and Adopted Accounting Pronouncements
Tabular disclosure of the components of cash, cash equivalents and Restricted Cash.
Schedule of Cash and Cash Equivalents and Restricted Cash [Table Text Block]
Schedule of cash and cash equivalents and restricted cash
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Antidilutive securities excluded from computation of earnings per share
Unrealized Gain (Loss) on Investments [Table Text Block]
Schedule of cost and fair value of cash equivalents and short-term investments
Debt Securities, Available-for-sale [Table Text Block]
Schedule of available-for-sale debt securities
Fair Value, Assets Measured on Recurring Basis [Table Text Block]
Schedule of fair value of the company's financial assets
Schedule of Finite-Lived Intangible Assets [Table Text Block]
Schedule of gross carrying amounts and net book value of intangible assets
Schedule of Inventory, Current [Table Text Block]
Schedule of inventories
Disaggregation of Revenue [Table Text Block]
Schedule of disaggregation of revenue
Tabular disclosure for gross to net adjustments recorded in revenue.
Schedule Of Gross to Net Adjustments in Revenue [Table Text Block]
Schedule of GTN adjustments recorded in revenue
Schedules of Concentration of Risk, by Risk Factor [Table Text Block]
Schedule of the amount and percentage of gross revenue attributable to customers that represented more than 10% of the Company's gross revenue and all other customers as a group
Property, Plant and Equipment [Table Text Block]
Schedule of Property and equipment
Schedule of Accrued Liabilities [Table Text Block]
Schedule of accrued expenses
Share-based Compensation, Stock Options, Activity [Table Text Block]
Schedule of status of stock options
Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Schedule of RSU activity including PRSUs
Schedule of Compensation Cost for Share-based Payment Arrangements, Allocation of Share-based Compensation Costs by Plan [Table Text Block]
Schedule of stock-based compensation by type of award
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Summary of company's revenue, expenses and net loss for the segment and is reconciled to net loss on a consolidated basis
Tabular disclosure of supplemental balance sheet information related to leases
Supplemental Balance Sheet Information Related To Leases [Table Text Block]
Schedule of balance sheet classification of the Company's right-of-use asset and lease liabilities
Lease, Cost [Table Text Block]
Schedule of components of lease expenses
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Schedule of minimum lease commitments
Cash includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the customer may deposit additional funds at any time and effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid Investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Short-term investments, exclusive of cash equivalents, generally consist of marketable securities intended to be sold within one year (or the normal operating cycle if longer) and may include trading securities, available-for-sale securities, or held-to-maturity securities (if maturing within one year), as applicable.
Cash, Cash Equivalents and Short-term Investments and Restricted Cash Total
Cash, cash equivalents, short-term investments, and restricted cash
Restricted Cash
Restricted cash
Disclosure of information about significant accounting policies.
Accounting Policies [Table]
Restricted Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents [Domain]
Represents the cash restricted for the benefit of the landlord for its commercial manufacturing facility.
Commercial manufacturing facility
Commercial manufacturing facility
Range [Axis]
Range [Domain]
Minimum
Minimum
Maximum
Maximum
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES.
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Amount of impairment of investment in debt security, measured at amortized cost (held-to-maturity), charged against allowance for credit loss.
Debt Securities, Available-for-Sale, Allowance for Credit Loss, Impairment Loss
Impairment losses related to credit losses
Security Deposit
Security deposit
Amount of minimum restricted security deposit to be maintained.
Minimum Restricted Security Deposit
Restricted security deposit
The amount of decrease in letters of credit on lease expiration.
Decrease in Letters of Credit on Lease Expiration
Decrease in letters of credit
The payment term of customers.
Customer Payment Term
Customer payment term
Antidilutive Securities [Axis]
Antidilutive Securities, Name [Domain]
Stock option expense
Restricted stock units
Restricted stock units
Restricted stock expense
Represents information pertaining to employee stock purchase plan.
Employee Stock Purchase Plan
Employee Stock Purchase Plan
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Antidilutive securities excluded from calculation of net loss per share
Number of Operating Segments
Number of operating segment
Number of operating segments
Schedule of Cash and Cash Equivalents [Table]
Financial Instrument [Axis]
Financial Instruments [Domain]
U.S. treasury securities
U.S. treasury securities
Money market funds
Money market funds
Cash and Cash Equivalents [Line Items]
CASH EQUIVALENTS AND INVESTMENTS
Available-for-sale Securities, Amortized Cost Basis
Amortized Cost
Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax
Gross Unrealized Gains
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax
Gross Unrealized Losses
Available-for-sale Securities
Total investments
Fair Value
Cash Equivalents, at Carrying Value
Cash equivalents total
Cash equivalents
Debt Securities, Available-for-sale, Current
Short-term investments
Cash and Cash Equivalents [Axis]
Demand Deposits
Demand Deposits
Debt Securities, Available-for-sale, Unrealized Loss
Unrealized losses on available-for-sale
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Number of Positions
Number of investments in debt securities in continuous unrealized loss position for more than 12 months
Measurement Frequency [Axis]
Fair Value, Measurement Frequency [Domain]
Recurring
Recurring
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Level 1
Level 1
Assets, Fair Value Disclosure
Total
Schedule of Finite-Lived Intangible Assets [Table]
Finite-Lived Intangible Assets by Major Class [Axis]
Finite-Lived Intangible Assets, Major Class Name [Domain]
Developed technology
Developed technology
Represents the assembled workforce acquired in an asset acquisition.
Assembled Workforce [Member]
Assembled workforce
Intellectual Property [Member]
Intellectual property license
Patents [Member]
Patents
Finite-Lived Intangible Assets [Line Items]
INTANGIBLE ASSETS, NET
Finite-Lived Intangible Assets, Net [Abstract]
Gross carrying amounts and net book value of intangible assets
Finite-Lived Intangible Assets, Gross
Total intangible assets
Finite-Lived Intangible Assets, Accumulated Amortization
Less: accumulated amortization
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets excluding non-cash amortization expense.
Amortization of Intangible Assets Excluding Non-Cash Amortization Expense
Amortization expense
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Total estimated amortization of the Company's intangible assets:
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Remainder of the year ending December 31, 2026
Finite-Lived Intangible Asset, Expected Amortization, Year One
Year ending December 31, 2027
Finite-Lived Intangible Asset, Expected Amortization, Year Two
Year ending December 31, 2028
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Year ending December 31, 2029
Finite-Lived Intangible Asset, Expected Amortization, Year Four
Year ending December 31, 2030
Asset Acquisition [Axis]
Asset Acquisition [Domain]
Represents the information pertaining to Proleukin (aldesleukin), product used in the Amtagvi treatment regimen.
PROLEUKIN [Member]
Proleukin
Finite-Lived Intangible Asset, Useful Life
Expected useful life of intangible assets
Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life
Weighted average amortization period
Represents the deferred consideration term for completion of the Acquisition.
Asset Acquisition, Deferred consideration term
Deferred consideration term
The cash outflow for payment of contingent consideration associated with the asset acquisition.
Payments of Contingent Consideration for Asset Acquisition
Contingent consideration paid for acquisition
Finite-Lived Intangible Assets Acquired
Finite-lived intangible assets
Inventory, Net [Abstract]
INVENTORY
Inventory, Raw Materials, Net of Reserves
Raw materials
Inventory, Work in Process, Net of Reserves
Work in process
Inventory, Finished Goods, Net of Reserves
Finished goods
Aggregate carrying value as of the balance sheet date of the inventory after valuation and LIFO reserves.
Inventory, Net, Current and Noncurrent
Total inventory
Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels includes expense from PY.
Inventory Write-down Including Expense From PY
Excess and obsolescence reserve
Inventory, Noncurrent
Inventory as long-term other assets
Disaggregation of Revenue [Table]
Product and Service [Axis]
Product and Service [Domain]
Represents the information pertaining to Amtagvi (lifileucel), the first product within its autologous TIL cell therapy platform.
Amtagvi [Member]
Amtagvi
Disaggregation of Revenue [Line Items]
REVENUE
Amount, before adjustments, of revenue from satisfaction of performance obligation by transferring promised good or service to customer.
Revenue From Contract With Customer, Gross
Gross revenue
Gross revenue
n/a
Revenue From Contract with Customer, Gross to Net Adjustments [Abstract]
GTN adjustments:
Amount of adjustments to revenue from contract from customer for Government rebates and chargebacks.
Adjustments For Government Rebates And Chargebacks
Government rebates and chargebacks
Amount of adjustments to revenue from contract from customer for wholesaler fees and cash discounts.
Adjustments For Wholesaler Fees And Cash Discounts
Wholesaler fees and cash discounts
Amount of adjustments to revenue from contract from customer for other rebates, returns, discounts and adjustments.
Adjustments For Other Rebates, Returns, Discounts And Adjustments
Other rebates, returns, discounts and adjustments
Amount of adjustments from gross revenues to net revenues from contract with customers.
Revenue From Contract With Customer, Gross To Net Adjustments
GTN adjustments
Total GTN adjustments
Geographical [Axis]
Geographical [Domain]
UNITED STATES
United States
Non-US
Rest of world
For an entity that discloses threshold for concentration of credit risk of customers.
Threshold For Concentration Of Credit Risk
Threshold for concentration of credit risk
Concentration Risk [Table]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Domain]
Revenue from Contract with Customer Benchmark [Member]
Revenue
Concentration Risk Type [Axis]
Concentration Risk Type [Domain]
Customer Concentration Risk [Member]
Customer concentration
Customer [Axis]
Customer [Domain]
Represents information pertaining to Customer A.
Customer A [Member]
Customer A
Represents information pertaining to other customers.
Other Customers [Member]
Other customers
Concentration Risk [Line Items]
REVENUE
Concentration Risk, Percentage
Concentration risk (in percent)
Property, Plant and Equipment [Table]
Property, Plant and Equipment, Type [Axis]
Property, Plant and Equipment, Type [Domain]
Leasehold improvements
Leasehold improvements
Lab, process, and validation equipment
Lab, process, and validation equipment
Represents information pertaining to utility equipment.
Utility equipment
Utility equipment
Office furniture and equipment
Office furniture and equipment
Represents information pertaining to computer software.
Computer Software [Member]
Computer software
Computer equipment
Computer equipment
Machinery and equipment
Machinery and equipment
Construction in progress
Construction in progress
Property, Plant and Equipment [Line Items]
PROPERTY AND EQUIPMENT, NET
Property, Plant and Equipment, Gross
Total property and equipment, cost
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Less: Accumulated depreciation and amortization
Accrued Employee Benefits, Current
Accrued payroll and employee related expenses
Carrying value as of the balance sheet date of obligations incurred through that date and payable for clinical and related services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Clinical Related Expenses Current
Clinical related
Carrying value as of the balance sheet date of obligations incurred through that date and payable for manufacturing of the entity's goods and services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Manufacturing Related Expenses Current
Manufacturing related
Carrying value as of the balance sheet date of obligations incurred through that date and payable for commercial manufacturing facility related services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Commercial Manufacturing Facility Related Current
Facilities related
Accrued Professional Fees, Current
Legal and related services
Carrying value as of the balance sheet date of obligations incurred through that date and payable for legal and related services. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Accrued Inventory, Current
Inventory and distribution related
Other Accrued Liabilities, Current
Other accrued expenses
Accrued Liabilities, Current
Total accrued expenses
Schedule of Stock by Class [Table]
Plan Name [Axis]
Plan Name [Domain]
Twenty Eighteen Equity Incentive Plan Member.
The 2018 Plan
The 2018 Plan
Two Thousand Twenty Espp Member.
2020 ESPP
2020 ESPP
ESPP expense
Represents information pertaining to Two Thousand Twenty One Inducement Plan.
2021 Inducement Plan
2021 Inducement Plan
Represents information pertaining to Restricted Stock Units (RSUs) including Performance-Based Restricted Stock Units (PRSUs).
RSUs and PRSUs
RSUs and PRSUs
Represents the information pertaining to Blank Check.
Blank check
Blank check
Sale of Stock [Axis]
Sale of Stock [Domain]
Private Placement
Private Placement
IPO
IPO
Represents information pertaining to at the market offering program.
At the Market Offering Program
At the Market Offering Program
Information pertaining to the a new Open Market Sales Agreement (the "2023 Sales Agreement").
Sales Agreement 2023 [Member]
2023 Sales Agreement
Represents the member information pertaining to Amended and Restated Open Market Sale Agreement (the "2025 Sale Agreement").
Sale Agreement 2025 Member
2025 sales Agreement
Class of Stock [Line Items]
STOCKHOLDERS' EQUITY
Maximum amount of shares that can be issued under sale agreement.
Sales Agreement, Authorized Shares To Be Issued, Amount
Maximum amount of shares to be issued
Remaining amount of shares that can be issued under sale agreement.
Sales Agreement, Authorized Shares Remaining To Be Issued, Amount
Remaining amount of shares
Maximum percentage of gross sales proceeds that will be paid as commission under the sales agreement.
Sales Agreement, Commission, Maximum Percentage Of Gross Sales Proceeds
Maximum percentage of commission
Per share or per unit amount of equity securities issued in average price
Weighted Average Price Per Share
Weighted average price
The price per share at which the preferred stock of an entity is converted.
Convertible Price Per Shares
Convertible price per share
Conversion of Stock, Shares Issued
Conversion of stock, shares issued
Conversion of Stock, Shares Converted
Conversion of Stock, shares converted
The total number of shares of common stock into which the convertible preferred stock may be converted, at balance sheet date.
Convertible Preferred Stock Number Of Shares Of Common Stock Available Upon Conversion, Total
Common stock available in conversion, shares
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Shares authorized
Common Stock, Capital Shares Reserved for Future Issuance
Common stock, capital shares reserved for future issuance
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant
Number of shares available
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized
Total unrecognized compensation expense
Allocated Share-based Compensation Expense
Stock-based compensation expense
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition
Unrecognized compensation cost recognition period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted average grant date fair value, options granted
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent
Percentage of purchase price
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options
Unrecognized compensation cost
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested
Aggregate intrinsic value of outstanding non-vested RSUs & PRSUs
Stock Issued During Period, Shares, Conversion of Convertible Securities
Conversion of convertible preferred stock into common stock (in Shares)
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Option Indexed to Issuer's Equity, Type [Axis]
Option Indexed to Issuer's Equity, Type [Domain]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
STOCKHOLDERS' EQUITY
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of Options
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Outstanding, ending balance
Outstanding, beginning balance
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Issued
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Expired/Cancelled
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Ending vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Options exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Weighted Average Exercise Price
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Outstanding, ending balance
Outstanding, beginning balance
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Issued
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
Expired/Cancelled
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Ending vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Options exercisable
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRemainingContractualLife [Abstract]
Weighted Average Remaining Contractual Life (Years)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Options outstanding, remaining term
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term
Ending vested and expected to vest, remaining term
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Options exercisable, remaining term
n/a
Aggregate Intrinsic Value
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Option at ending balance
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Ending vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value
Option exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Number of Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Outstanding, Ending balance
Outstanding, Beginning Balance
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested/Released
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Canceled/Forfeited
Number of fully vested and expected to vest equity-based payment instruments outstanding, excluding stock (or unit) options.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Options, Vested and Expected to Vest, Outstanding, Number
Ending vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted Average Grant Date Fair Value
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Ending Balance
Weighted Average Grant Date Fair Value, Beginning Balance
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Vested/Released
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Canceled/forfeited
Per share or unit weighted-average fair value of fully vested and expected to vest equity-based payment instruments outstanding, excluding stock (or unit) options.
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instrument Other than Options, Vested and Expected to Vest, Outstanding, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Ending vested and expected to vest
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost
Total stock-based compensation expense
Share-Based Payment Arrangement, Amount Capitalized
Stock-based compensation expense
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]
Segments [Axis]
Segments [Domain]
Represents information pertaining to single reportable segment.
Single Reportable Segment [Member]
Single reportable segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
SEGMENT INFORMATION
Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization
Cost of goods sold (excluding depreciation and amortization)
The amount of share-based compensation included in cost of sales.
Stock-based Compensation Included in Cost of Sales
Stock-based Compensation
Royalty Expense
Royalties
Selling and Marketing Expense
Sales and marketing
Segment Reporting, Other Segment Item, Amount
Other segment items
Operating Expenses
Total expenses
Number of Reportable Segments
Number of reportable segments
Segment Reporting, Other Segment Item, Composition, Description
Other segment items
Disclosure of information about licenses and agreements.
Licenses and Agreements [Table]
Cooperative Research and Development Agreement
Represents information pertaining to Cellectis S.A.
Cellectis S.A
Represents the information pertaining to Novartis pharma AG and Related Entities License Agreement.
Novartis Pharma AG And Related Entities License Agreement [Member]
Novartis Pharma AG and Related Entities - License Agreement
Type of Arrangement and Non-arrangement Transactions [Axis]
Arrangements and Non-arrangement Transactions [Domain]
Represents information pertaining to second manufacturing and services agreement entered with Minaris Advanced Therapies.
Second Minaris Manufacturing And Services Agreement [Member]
Second Minaris Manufacturing and services agreement
This member stands for Patent License Agreement Related to the Development and Manufacture of TIL Therapies.
Patent License Agreement Related to the Development and Manufacture of TIL Therapies [Member]
Patent License Agreements Related to TIL Cell Therapies
This member stands for Second Amended and Restated Patent License Agreement.
Second Amended and Restated Patent License Agreement [Member]
Second Amended and Restated Patent License Agreement
Represents the information pertaining to patent license agreement related to the company sponsored Phase 2 Clinical Study in Melanoma.
Patent License Agreement, Related to Phase 2 Clinical Study in Melanoma [Member]
Phase 2 Clinical Study in Melanoma
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Licenses and Agreements [Line Items]
LICENSES AND AGREEMENTS
It represents the term of agreement.
Agreement Term
Agreement term
The required notification period before the party may terminate the agreement.
Notification Period To Terminate Agreement
Notification period to terminate agreement
Amount required to be remitted under the collaborative arrangement .
Collaborative Arrangement, Amount Required To Be Remitted
Amount of collaborative arrangement required to be remitted
Period within which the company is required to be remit the specified amount under the collaborative arrangement.
Collaborative Arrangement, Period To Remit Required Amount
Period of collaborative arrangement required to be remitted
The amortization of milestone payments.
License Agreement, Amortization of Milestone Payment
License agreement
The number of suites under the agreement.
Number Of Suites Under The Agreement
Number of suites under the agreement
Amount of expenses related to initiation of patient dosing, recorded during the period.
Patient Dosing Initiation Expenses
Patient dosing initiation expenses
Number of historical asset purchase agreement.
Number of Historical Asset Purchase Agreement
Number of historical asset purchase agreement
Number of historical master cell bank license and working cell bank transfer agreement.
Number of Historical Master Cell Bank License and Working Cell Bank Transfer Agreement
Number of historical master cell bank license and working cell bank transfer agreement
Number of historical license agreement.
Number of Historical License Agreement
Number of historical license agreement
The amount of milestone payments payable under the license agreement.
License Agreement Milestone Payments Payable
Amount of milestone payments payable under the license agreement
The percent of milestone payments reimbursable by deduction from deferred consideration.
License Agreement, Percent of Milestone Payments Reimbursable
Percent of milestone payments reimbursable
The amount of milestone payment made during the period under the license agreement.
License Agreement, Milestone Payment
Amount of milestone payment made during the period under the license agreement
Category of Item Purchased [Axis]
Long-term Purchase Commitment, Category of Item Purchased [Domain]
Represents information pertaining to manufacturing and supply agreement from Clinigen with Boehringer Ingelheim Biopharmaceuticals GmbH.
Manufacturing and Supply Agreement With Boehringer Ingelheim Biopharmaceuticals GmbH [Member]
Manufacturing and Supply Agreement With Boehringer Ingelheim Biopharmaceuticals GmbH
Represents the automatic renewal term of supply agreement.
Supply Agreement, Automatic Renewal Term
Renewal term of agreement
Purchase Obligation, to be Paid, Remainder of Fiscal Year
Remainder of the year ending December 31, 2026
Purchase Obligation, to be Paid, Year One
Years ending December 31, 2027
Purchase Obligation, to be Paid, Year Two
Years ending December 31, 2028
Lessee, Lease, Description [Table]
Lease Contractual Term [Axis]
Lease Contractual Term [Domain]
Represents the member information pertaining to sublease agreement ("the New Headquarters Lease").
Sub Lease Agreement [Member]
Sub Lease Agreement
Represents information relating to New Headquarters Lease.
New Headquarters Lease
Represents information manufacturing contracts.
Manufacturing Contracts [Member]
Manufacturing Contracts
Office Space
Office Space
Furniture and equipment
This member stands for Philadelphia, Pennsylvania.
Philadelphia, Pennsylvania
Philadelphia, Pennsylvania
This member stands for San Carlos, California.
San Carlos, California
San Carlos, California
Lessee, Lease, Description [Line Items]
LEASES
Area of Land
Area of land
Lessee, Operating Lease, Term of Contract
Term of contract in years
Number of options to extend the lease.
Lessee, Operating Lease, Number of Options to Extend Lease
Number of options to extend the lease
Lessee, Operating Lease, Option to Extend
Option to extend
Lessee, Operating Lease, Existence of Option to Extend [true false]
Existence of option to extend lease
Lessee, Operating Lease, Renewal Term
Renewal term in years
Percentage of increase in monthly base rent of lease from its current amount under extension option.
Lessee, Operating Lease, Extension, Percentage of Increase in Monthly Base Rent
Percentage of increase in monthly base rent upon extension
The amount of monthly base rent under operating lease of lessee.
Lessee, Operating Lease, Monthly Base Rent
Monthly base rent
Area of land surrendered.
Area of Land Surrendered
Area of land surrendered
The amount of cash outflow associated with the payment of early termination.
Lessee, Operating Lease, Amount of Early Lease Termination Fees Paid
Early termination payment
The amount of cash outflow associated with the payment of related brokerage fees.
Lessee, Operating Lease, Amount of Brokerage Fee Paid
Brokerage fees paid
Amount of derecognition of right of use assets at the time of termination or modification of lease agreement.
Derecognition Of Operating Lease Right-Of-Use Assets
Derecognition of operating lease right-of-use assets
mount of derecognition of lease liabilities at the time of termination or modification of lease agreement.
Derecognition Of Operating Lease Liabilities
Derecognition of operating lease liabilities
The aggregate amount of write-downs for impairments recognized during the period for long lived assets due to early termination of lease.
Impairment of Long-lived Assets Due to Early Termination of Lease
Impairment due to early termination
Represents the required advance notice period to terminate a lease arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Lease Termination Notice Period
Lease termination advance notice period
Operating Lease Liability [Abstract]
Operating lease liabilities
Operating Lease, Liability
Total operating lease liabilities
Operating lease liabilities
Operating Lease, Cost
Operating lease cost
Variable Lease, Cost
Variable lease cost
Short-term Lease, Cost
Short-term lease cost
Lease, Cost
Total lease cost
Operating Lease, Payments
Cash paid for amounts included in the measurement of lease liabilities included in cash flows from operations
Amount of increase (decrease) in right-of-use assets from lease modifications.
Increase /(Decrease) In Right-Of-Use Assets From Lease Modifications
Increase (decrease) in right-of-use assets from lease modifications
Operating Lease, Weighted Average Remaining Lease Term
Weighted-average remaining lease terms (years)
Operating Lease, Weighted Average Discount Rate, Percent
Weighted-average discount rates
Facility leases
Lessee, Operating Lease, Liability, Payments, Remainder of Fiscal Year
2026
Operating Leases, Future Minimum Payments, Due in Two Years
2027
Lessee, Operating Lease, Liability, Payments, Due Year Two
2028
Lessee, Operating Lease, Liability, Payments, Due Year Three
2029
Lessee, Operating Lease, Liability, Payments, Due Year Four
2030
Amount of lessee's undiscounted obligation for lease payment for operating lease due after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Lessee, Operating Lease, Liability, Payments, Due After Year Four
Thereafter
Lessee, Operating Lease, Liability, Payments, Due
Total lease payments
Operating Lease Present Value Adjustments
Less: Present value adjustment
Loss Contingencies [Table]
Litigation Case [Axis]
Litigation Case [Domain]
Information pertaining to lawsuit brought by Solomon Capital LLC et al.
Solomon Capital LLC Litigation
Loss Contingencies [Line Items]
LEGAL PROCEEDINGS
The number of shares allegedly issued in breach of fiduciary duty, during the period.
Shares Issued in Breach of Fiduciary Duty
Public offering
Proceeds from Other Debt
Proceeds from lawsuit filed
Debt Instrument, Face Amount
Face amount
Debt Instrument, Convertible, Number of Equity Instruments
Debt instrument, convertible, number of equity instruments
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse split ratio
Loss Contingency, Estimate of Possible Loss
Estimate of possible loss
Loss Contingency, Damages Sought, Value
Damages claimed
The amount of equity claim.
Equity Claim
Equity claim
Loss Contingency, New Claims Filed, Number
Number of new claims filed
The total number of new claims filed where the defendant has no direct liability or alleged wrongdoing.
Nominal Defendant, New Claims Filed, Number
Nominal defendant, number of new claims filed
Effective Income Tax Rate Reconciliation, Percent
Effective tax rates
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Federal statutory tax rate